Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| Line 20: | Line 20: | ||
*[[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| QIBA fMRI Profile 2017-06-19]] ''Open until September 19, 2017'' | *[[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| QIBA fMRI Profile 2017-06-19]] ''Open until September 19, 2017'' | ||
| − | '''Please submit all public comments through this online form: http://tinyurl.com/QIBA-Public-Comment-Form''' | + | ''' |
| + | == Please submit all public comments through this online form: http://tinyurl.com/QIBA-Public-Comment-Form == | ||
| + | ''' | ||
<br /><font size="2" color="red">(Note: if you have more than 10 comments, you may submit additional forms)</font> | <br /><font size="2" color="red">(Note: if you have more than 10 comments, you may submit additional forms)</font> | ||
Revision as of 15:01, 15 September 2017
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
The following Profiles are open for Public Comment:
- QIBA PET Amyloid Profile 2017-06-15 Open until September 15, 2017
- QIBA MRE Profile 2017-08-15 Open until September 15, 2017
- QIBA fMRI Profile 2017-06-19 Open until September 19, 2017
Please submit all public comments through this online form: http://tinyurl.com/QIBA-Public-Comment-Form
(Note: if you have more than 10 comments, you may submit additional forms)
Public Comment closed:
- DWI Profile 2017-04-27 (Closed on August 25, 2017)
- QIBA Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening Profile 2016-06-01 (Closed Sept 2016)
- DCE-MRI Quantification 2011-12-13 (Closed Feb 2012)
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)